EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exploration of pharmacological interventions to prevent isoproterenol-induced myocardial infarction in experimental models

Monika Garg, Deepa Khanna

Therapeutic Advances in Cardiovascular Disease · 2014-08 · 8 (4) · 155-169

DOI: 10.1177/1753944714531638 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, online erschienen am 09.05.2014. Verfasst von Monika Garg und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Pharmacology Division Department of Pharmacology Rajendra Institute of Technology and Sciences India. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 130 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High incidences of myocardial infarction associated with high morbidity and mortality, are a major concern and economic burden on industrialized nations. Persistent β-adrenergic receptor stimulation with isoproterenol leads to the development of oxidative stress, myocardial inflammation, thrombosis, platelet aggregation and calcium overload, which ultimately cause myocardial infarction. Therapeutic agents that are presently employed for the prevention and management of myocardial infarction are beta-blockers, antithrombotics, thrombolytics, statins, angiotensin converting enzyme inhibitors, angiotensin II type 1 receptor blockers, calcium channel blockers and nitrovasodilators. In spite of effective available interventions, the mortality rate of myocardial infarction is progressively increasing. Thus, there has been a regular need to develop effective therapies for the prevention and management of this insidious disease. In this review, the authors give an overview of the consequences of isoproterenol in the pathogenesis of cardiac disorders and various therapeutic possibilities to prevent these disorders.

Schlagwörter

Stichwörter der Autor:innen

atherosclerosiscalcium overloadinflammationisoproterenoloxidative stressreactive oxygen species

Autor:innen und Institutionen

  • Cardiovascular Pharmacology Division Department of Pharmacology Rajendra Institute of Technology and Sciences India.
  • Department of Pharmacology, Cardiovascular Pharmacology Division, Institute of Pharmacy, Rajendra Institute of Technology and Sciences [RITS], Sirsa-125 055, India 7drdeepa@gmail.com.

Zitieren

APA

Garg, M., & Khanna, D. (2014). Exploration of pharmacological interventions to prevent isoproterenol-induced myocardial infarction in experimental models. Therapeutic Advances in Cardiovascular Disease, 8(4), 155-169. https://doi.org/10.1177/1753944714531638

Vancouver

Garg M, Khanna D. Exploration of pharmacological interventions to prevent isoproterenol-induced myocardial infarction in experimental models. Therapeutic Advances in Cardiovascular Disease. 2014;8(4):155-169. doi:10.1177/1753944714531638

BibTeX
@article{Garg2014,
  author = {Garg, Monika and Khanna, Deepa},
  title = {Exploration of pharmacological interventions to prevent isoproterenol-induced myocardial infarction in experimental models},
  journal = {Therapeutic Advances in Cardiovascular Disease},
  year = {2014},
  volume = {8},
  number = {4},
  pages = {155--169},
  doi = {10.1177/1753944714531638}
}
Kostenlos starten →